Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEZIGDOMIDE for Plasma cell myeloma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where MEZIGDOMIDE was used for Plasma cell myeloma.

Most Reported Side Effects for MEZIGDOMIDE

Side Effect Reports % Deaths Hosp.
Infection 11 39.3% 2 7
Pneumonia 11 39.3% 2 8
Covid-19 10 35.7% 2 8
Off label use 8 28.6% 1 6
Plasma cell myeloma refractory 7 25.0% 1 6
Delirium 6 21.4% 0 6
Neutropenia 6 21.4% 2 1
Pyrexia 6 21.4% 0 6

Other Indications for MEZIGDOMIDE

Plasma cell myeloma refractory (10)

Other Drugs Used for Plasma cell myeloma

LENALIDOMIDE (273,951) POMALIDOMIDE (81,096) DEXAMETHASONE (49,067) BORTEZOMIB (31,567) DARATUMUMAB (19,119) IXAZOMIB (17,602) CARFILZOMIB (15,333) THALIDOMIDE (10,689) CYCLOPHOSPHAMIDE (9,148) REVLIMID (7,122)

Related Pages

MEZIGDOMIDE Full Profile All Plasma cell myeloma Drugs MEZIGDOMIDE Demographics MEZIGDOMIDE Timeline